Evidence map›Paper›PMID 29185442›Full record

ArticleNature communications2017

Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading.

Ido Goldstein, Ville Paakinaho, Songjoon Baek, Myong-Hee Sung, Gordon L Hager

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Contradictory Role of Gadd45β in Liver Diseases.Journal of cellular and molecular medicine · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Unveiling therapeutic avenues targeting xCT in head and neck cancer.Cellular oncology (Dordrecht, Netherlands) · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ido GoldsteinLaboratory of Receptor Biology and Gene Expression, CCR, NCI, NIH, Bethesda, MD, 20892, USA. goldstein.ido@gmail.com.
Ville PaakinahoLaboratory of Receptor Biology and Gene Expression, CCR, NCI, NIH, Bethesda, MD, 20892, USA.
Songjoon BaekLaboratory of Receptor Biology and Gene Expression, CCR, NCI, NIH, Bethesda, MD, 20892, USA.
Myong-Hee SungLaboratory of Molecular Biology and Immunology, NIA, NIH, Baltimore, MD, 21224, USA.
Gordon L HagerLaboratory of Receptor Biology and Gene Expression, CCR, NCI, NIH, Bethesda, MD, 20892, USA. hagerg@dce41.nci.nih.gov.
National Institutes of Health · USProtein Express (United States) · US

Funding

Chromatin Structure and Gene ExpressionZIABC005450 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HAGER, GORDON L · 2009 to 2025
$35.2M
6 · The paper itself

Abstract

The cytokines interleukin 1β and 6 (IL-1β, IL-6) mediate the acute phase response (APR). In liver, they regulate the secretion of acute phase proteins. Using RNA-seq in primary hepatocytes, we show that these cytokines regulate transcription in a bifurcated manner, leading to both synergistic and antagonistic gene expression. By mapping changes in enhancer landscape and transcription factor occupancy (using ChIP-seq), we show that synergistic gene induction is achieved by assisted loading of STAT3 on chromatin by NF-κB. With IL-6 treatment alone, STAT3 does not efficiently bind 20% of its coordinated binding sites. In the presence of IL-1β, NF-κB is activated, binds a subset of enhancers and primes their activity, as evidenced by increasing H3K27ac. This facilitates STAT3 binding and synergistic gene expression. Our findings reveal an enhancer-specific crosstalk whereby NF-κB enables STAT3 binding at some enhancers while perturbing it at others. This model reconciles seemingly contradictory reports of NF-κB-STAT3 crosstalk.

Indexed as

Acute-Phase ReactionAnimalsBinding SitesCells, CulturedChromatin ImmunoprecipitationEnhancer Elements, GeneticGene Expression RegulationHepatocytesInterleukin-1betaInterleukin-6MaleMice, Inbred C57BLNF-kappa BRNA Polymerase IISTAT3 Transcription FactorTranscription FactorsInterleukin-1betaInterleukin-6NF-kappa BRNA Polymerase IIStat3 protein, mouseSTAT3 Transcription FactorTranscription Factors

Identifiers

PMID29185442
PMCPMC5707366
OpenAlexW2770530503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.